A Murine Model of Ischemic Retinal Injury Induced by Transient Bilateral Common Carotid Artery Occlusion
November 12th, 2020
7.4K views
Here, we describe a mouse model of retinal ischemia by transient bilateral common carotid artery occlusion using simple sutures and a clamp. This model can be useful for understanding the pathological mechanisms of retinal ischemia caused by cardiovascular abnormalities.
Overview
This article describes a mouse model of retinal ischemia induced by transient bilateral common carotid artery occlusion. This model is beneficial for studying the pathological mechanisms underlying retinal ischemia associated with cardiovascular issues.
Key Study Components
Area of Science
- Neuroscience
- Ophthalmology
- Pathophysiology
Background
- Retinal ischemia can result from various vascular diseases.
- Understanding the mechanisms can aid in developing therapeutic strategies.
- Current methods often require complex surgical instruments.
- This model aims to simplify the procedure and reduce operation time.
Purpose of Study
- To establish a reliable mouse model for retinal ischemia.
- To investigate the pathophysiology of ischemic retinopathies.
- To facilitate in vivo drug screening for potential treatments.
Methods Used
- Transient bilateral common carotid artery occlusion.
- Utilization of simple sutures and a clamp.
- Preparation of surgical instruments with sterilization protocols.
- Demonstration of the procedure by trained personnel.
Main Results
- The model effectively induces retinal ischemia.
- It allows for the study of various ischemic conditions.
- Reduces the need for multiple surgical tools.
- Shortens the overall operation time.
Conclusions
- This model provides a valuable tool for research in retinal ischemia.
- It enhances understanding of ischemic retinopathies.
- The simplified method may improve experimental efficiency.
Frequently Asked Questions
What is the significance of this mouse model?
It helps in understanding retinal ischemia and testing potential treatments.
How does this model simplify the procedure?
By using simple sutures and a clamp, it reduces reliance on complex instruments.
Who demonstrates the procedure?
Deokho Lee, a PhD student, along with assistant professor Yukihiro Miwa.
What are the potential applications of this model?
It can be used for studying ischemic retinopathies and drug screening.
What preparations are needed before the procedure?
All surgical instruments should be autoclaved and kept in 70% ethyl alcohol.
What diseases can be studied using this model?
It can help in understanding diabetic retinopathy and ocular ischemic syndrome.
Executive Industry Relevance
This murine model of transient bilateral common carotid artery occlusion provides a simplified, reproducible system for studying retinal ischemia pathophysiology, directly supporting target validation in ischemic retinopathies. By reducing surgical complexity and occlusion time, it enables efficient in vivo drug screening and mechanistic de-risking for vascular disease therapeutics. The model aligns with early discovery workflows where predictive confidence in target engagement and pathway modulation is critical for portfolio prioritization.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses in retinal ischemia models through quantifiable HIF-1 alpha stabilization and retinal dysfunction readouts.
- Operational Value: Uses minimal instrumentation (sutures and clamp) to standardize ischemic induction across study cohorts.
- Scientific Value: Supports biological de-risking by reproducing key ischemic phenotypes including retinal thinning, gliosis, and ERG b-wave amplitude reduction.
Screening & Assay Development
- Scientific Value: Generates consistent retinal thickness and reactive gliosis metrics for compound screening in vivo.
- Operational Value: Shortens procedure time versus traditional MCAO models, improving throughput for pharmacokinetic and pharmacodynamic assessments.
- Scientific Value: Provides bilateral internal control (left retina) to reduce variability in drug efficacy measurements.
Translational & Preclinical Research
- Scientific Value: Mimics human ocular ischemic conditions (e.g., diabetic retinopathy, ocular ischemic syndrome) to bridge discovery to preclinical validation.
- Operational Value: Facilitates testing of hypertension or hypoglycemia as disease modifiers in ischemic retinopathy models.
- Scientific Value: Enables longitudinal monitoring of retinal structure (OCT) and function (ERG) to assess therapeutic impact over time.
Pipeline & Workflow Integration
The model fits within the discovery-to-preclinical continuum by providing a disease-relevant system for target validation and lead compound evaluation in ischemic retinopathy research.
- Discovery Biology: Supports pathway clarification via HIF-1 alpha stabilization and glial activation readouts after transient ischemia.
- Screening: Delivers quantitative, reproducible outputs (retinal thickness, b-wave amplitude) for compound effect comparison.
- Analytics: Enables statistical comparison of ischemic severity across treatment groups using ERG and immunohistochemistry endpoints.
- Translational Research: Models human-relevant ischemic retinopathies to inform preclinical mechanism of action studies.
- Enterprise Reuse: Establishes a standardized ischemia induction platform adaptable across multiple labs and compound testing campaigns.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target modulation by linking carotid occlusion to defined retinal ischemic cascades.
- Operational Value: Reduces procedural variability and animal mortality through simplified suture/clamp technique.
- Strategic Value: Improves go/no-go decision efficiency by providing early pathophysiological readouts in a high-throughput compatible format.
- Portfolio Impact: Enables risk-adjusted prioritization of compounds targeting retinal ischemia mechanisms.
Implementation Considerations
- Requires microsurgical expertise for carotid artery isolation and suture placement.
- Depends on sterile instrumentation and precise occlusion timing (2-second left CCA clamp).
- Necessitates standardized postoperative care (atipamezole, butorphanol) for consistent recovery.
- Must adapt occlusion parameters when testing comorbid conditions like hypertension or hypoglycemia.
- Relies on validated endpoints (HIF-1 alpha, GFAP, ERG, OCT) for cross-study comparability.
Biopharma FAQs
Why does HIF-1 alpha stabilization matter for target validation in retinal ischemia?
HIF-1 alpha stabilization in the right retina at three and six hours post-occlusion serves as a quantifiable biomarker of hypoxic response, enabling assessment of pathway engagement in target validation studies.
How does isolating the left CCA as an internal control improve discovery pipeline efficiency?
Using the non-occluded left retina as an internal control reduces inter-animal variability in retinal thickness and gliosis measurements, increasing statistical power in compound screening.
What quantitative dependent variable measurements enable lead identification in this model?
Retinal thickness via OCT and b-wave amplitude via dark-adapted ERG provide objective, longitudinal readouts to compare ischemic severity and therapeutic effect across treatment groups.
Why do replication requirements matter for cross-functional collaboration in ischemic retinopathy studies?
Reproducible induction of retinal dysfunction and reactive gliosis across cohorts ensures consistent data transfer between discovery, preclinical, and translational teams for aligned decision-making.
What statistical analysis capabilities are required before implementing this model in drug screening workflows?
The model requires capacity for comparing ERG amplitudes, OCT thickness, and immunohistochemistry scores between occluded and control retinas using standardized parametric or non-parametric tests.
